[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Savara Inc (SVRA)

Savara Inc (SVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Savara Inc 1717 LANGHORE NEWTOWN ROAD SUITE 300 LANGHORNE PA 19047 USA

www.savarapharma.com Employees: 70 P: 512-614-1848

Sector:

Medical

Description:

Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,057,398
Enterprise Value, $K 1,054,128
Shares Outstanding, K 204,922
Float, K 194,061
% Float 94.70%
Short Interest, K 27,672
Short Float 13.50%
Days to Cover 22.87
Short Volume Ratio 0.67
% of Insider Shareholders 5.30%
% of Institutional Shareholders 87.93%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -118,840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -32,240 K
EBIT, $ -123,470 K
EBITDA, $ -125,640 K

Growth:

1-Year Return 60.09%
3-Year Return 159.30%
5-Year Return 230.77%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 03/13/26
Next Earnings Date 05/12/26 [--]
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr 7.14%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-70 on 04/28/17

SVRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -84.01%
Return-on-Assets % -63.60%
Profit Margin % 0.00%
Debt/Equity 0.15
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.28
Book Value/Share 1.00
Interest Coverage -1.83
60-Month Beta 0.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.